496 filings
Page 5 of 25
3
Andrea Matthews
19 Apr 23
Astria Therapeutics / Andrea Matthews ownership change
8:09am
PRE 14A
ATXS
Astria Therapeutics Inc
Preliminary proxy
6 Apr 23
4:00pm
8-K
ATXS
Astria Therapeutics Inc
31 Mar 23
Departure of Directors or Certain Officers
8:00am
10-K
2022 FY
ATXS
Astria Therapeutics Inc
Annual report
22 Mar 23
4:02pm
8-K
ATXS
Astria Therapeutics Inc
22 Mar 23
Astria Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides a Corporate Update
8:07am
SC 13G/A
ATXS
Astria Therapeutics Inc
14 Feb 23
Astria Therapeutics / Altium Capital Management ownership change
3:59pm
SC 13G/A
Fairmount Funds Management LLC
14 Feb 23
Astria Therapeutics / Fairmount Funds Management ownership change
3:45pm
SC 13G/A
Cormorant Asset Management, LP
14 Feb 23
Astria Therapeutics / Cormorant Asset Management ownership change
3:03pm
SC 13G/A
Deep Track Capital, LP
14 Feb 23
Astria Therapeutics / Deep Track Capital ownership change
8:27am
SC 13G/A
ATXS
Astria Therapeutics Inc
14 Feb 23
Astria Therapeutics / Vivo Opportunity ownership change
12:00am
8-K
ATXS
Astria Therapeutics Inc
2 Feb 23
Departure of Directors or Certain Officers
4:03pm
SC 13G
ATXS
Astria Therapeutics Inc
10 Jan 23
Astria Therapeutics / FMR ownership change
12:48pm
8-K
ATXS
Astria Therapeutics Inc
5 Jan 23
Corporate Presentation January 2023 1 Confidential
8:00am
SC 13G
Deep Track Capital, LP
22 Dec 22
Astria Therapeutics / Deep Track Capital ownership change
4:02pm
4
Perceptive Advisors LLC
21 Dec 22
Astria Therapeutics / JOSEPH EDELMAN ownership change
4:52pm
SC 13D/A
Perceptive Advisors LLC
21 Dec 22
Astria Therapeutics / PERCEPTIVE ADVISORS ownership change
4:30pm
SC 13G
Altium Capital Management LP
21 Dec 22
Astria Therapeutics / Altium Capital Management ownership change
2:12pm
8-K
ATXS
Astria Therapeutics Inc
15 Dec 22
Astria Therapeutics Announces Pricing of $100 Million Underwritten Offering of Common Stock
5:18pm
424B5
ATXS
Astria Therapeutics Inc
15 Dec 22
Prospectus supplement for primary offering
5:16pm
8-K
ATXS
Astria Therapeutics Inc
15 Dec 22
Astria Therapeutics Announces Positive Preliminary Results from the Phase 1a Clinical Trial of STAR-0215 in Healthy Subjects
6:00am